Showing results (651-660 of 903) with videos related to

Sort By:
Pageof 91
Hepatology (Baltimore, Md.)|May 9, 2015
The BH3-only protein BID impairs the p38-mediated stress response and promotes hepatocarcinogenesis during chronic liver injury in miceJohanna Orlik, Sven Schüngel, Laura Elisa Buitrago-Molina, et al.
Antiviral Therapy|June 9, 2006
Viral kinetics in patients with chronic hepatitis C treated with the serine protease inhibitor BILN 2061Eva Herrmann, Stefan Zeuzem, Christoph Sarrazin, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 20, 2018
Clinical significance of detectable and quantifiable HCV RNA at the end of treatment with ledipasvir/sofosbuvir in GT1 patientsBenjamin Maasoumy, Peter Buggisch, Stefan Mauss, et al.
Cancers|December 5, 2019
Potent Antitumor Activity of Liposomal Irinotecan in an Organoid- and CRISPR-Cas9-Based Murine Model of Gallbladder CancerZulrahman Erlangga, Katharina Wolff, Tanja Poth, et al.
Journal of Intensive Care Medicine|October 25, 2019
Nonocclusive Mesenteric Ischemia and Interventional Local Vasodilatory Therapy: A Meta-Analysis and Systematic Review of the LiteratureKlaus Stahl, Nina Rittgerodt, Markus Busch, et al.
Cells|June 21, 2019
Identification of Keratin 23 as a Hepatitis C Virus-Induced Host Factor in the Human LiverVolker Kinast, Stefan L Leber, Richard J P Brown, et al.
Clinical and Molecular Hepatology|June 4, 2025
Distinct inflammatory imprint in non-cirrhotic and cirrhotic patients before and after direct-acting antiviral therapyMoana Witte, Carlos Oltmanns, Jan Tauwaldt, et al.
Hepatology (Baltimore, Md.)|June 28, 2003
Interleukin 6/gp130-dependent pathways are protective during chronic liver diseasesKonrad L Streetz, Frank Tacke, Ludger Leifeld, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 27, 2015
Viral Infection of Tumors Overcomes Resistance to PD-1-immunotherapy by Broadening Neoantigenome-directed T-cell ResponsesNorman Woller, Engin Gürlevik, Bettina Fleischmann-Mundt, et al.
Gut|May 15, 2012
Urine proteomic analysis differentiates cholangiocarcinoma from primary sclerosing cholangitis and other benign biliary disordersJochen Metzger, Ahmed A Negm, Ruben R Plentz, et al.
Pageof 91